10 min read
September 29, 2021
Benzinga – Digital Therapeutics And The Future Of Psychedelic Medicine
Part of MINDCURE’s broad development plan includes completing the first stage of manufacturing pharmaceutical-grade ibogaine for research purposes. MINDCURE is also building digital therapeutics platform iSTRYM to optimize the healing journey at all stages. Features include data capture, data analysis and a protocols library. The company recently commenced a partnership with Speak AI involving custom-built integrations within iSTRYM.